Article
MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype.
Oncotarget - 10 May 2015
Yan Wei, Liu Yanwei, Yang Pei, Wang Zheng, You Yongping, Jiang Tao
Abstract excerpt
Accumulating evidence demonstrates that defining molecular subtypes based on objective genetic alterations may permit a more rational, patient-specific approach to molecular targeted therapy across various cancers. The objective of this study was to subtype primary glioblastoma (pGBM) based on MicroRNA (miRNA) profiling in Chinese population. Here, miRNA expression profiles from 82 pGBM samples were analyzed and...
Topics
Join the communities discussing this publication.